EGFR and neoplasm: Cetuximab has been shown to inhibit the proliferation of various EGFR over-expressed malignant cell lines in vitro and enhance the anti-tumor activity of several chemotherapeutic drugs or radiotherapy in mouse xenograft models [29–31].